Department of Infectious Diseases, Slovak University of Technology in Bratislava, Bratislava, Slovakia
Opinion
Findings from a Phase III Clinical Trial for the Groundbreaking COVID-19 Vaccine in Evaluating Immunogenicity and Safety
Author(s): Milazzo Laura*
The world has been grappling with the COVID-19 pandemic for over two years, and the development of effective vaccines has been a crucial step
towards controlling the spread of the virus. Among the many vaccines developed, a novel COVID-19 vaccine has emerged as a potential gamechanger
in the fight against the virus. In this article, we delve into the findings from a Phase III clinical trial that evaluated the immunogenicity and
safety of this groundbreaking vaccine. The Phase III clinical trial aimed to assess the effectiveness, immunogenicity, and safety profile of the novel
COVID-19 vaccine in a large-scale population. The trial enrolled a diverse group of participants across different age groups, demographics and
geographical locations to ensure a representative sample... Read More»
DOI:
10.37421/2795-6172.2023.7.197
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 